IVF

INVO Fertility, Inc.

$2.50

6.38%
SectorHealthcareIndustryMedical DevicesCountryUnited States

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Source: Yahoo Finance
AI summary

Price & performance

1M-47.5%
3M-49.2%
YTD-89.4%
1Y-97.4%
52-week range—
Beta0.30
Full chart and returns against a benchmark

Q-Score

27/ 100

Quality against peers; 50 is the peer median.

Growth25
Risk22
Performance21
Valuation56
Profitability40
Leverage31
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$6.8M+4.3%
Net income-$23.3M
Net margin-340.9%-199.8 pts
Historical fundamentals

Red flags in filings

6active red flags
Going-concern doubtJun 2, 2026
Material weakness in controlsJun 2, 2026
Restated financialsJun 2, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

IVFIndustryP/E—29.61P/S0.403.49EV/EBITDA—18.38P/B0.183.39PEG——
Dividend yield0.00%
Every valuation metric